|1.85|| -0.05 / -2.63%|
Neuralstem, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of treatments based on human neuronal stem cells and small molecule compounds. It develops biotherapeutic products to treat and cure neurodegenerative and neurological disorders of the brain and spinal cord, including Parkinson's, Alzheimer's, stroke, multiple sclerosis, spinal cord injury and epilepsy. The company was founded by I. Richard Garr, Karl Johe and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
|Karl Y. Johe||Chairman & Chief Scientific Officer|
|I. Richard Garr||President, CEO, CFO, Director & Legal Counsel|
|Thomas Hazel||Senior Vice President-Research|